Gene Query: CWC22

Dataset Description Geneva Score
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 30.66
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 24.47
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 22.66
Identification of transcription start sites for human A549 cell line using ReCappable-seq 19.56
R430: A potent inbibitor of DNA and RNA viruses 18.75
Human cell line and subcutaneous tumor 16.43
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 14.34
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 14.06
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 13.89
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 13.89
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 13.36
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 12.77
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 12.77
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 12.71
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 12.65
mRNA sequencing of oropharyngeal cancer cell lines 11.96
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 11.23
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 11.23
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 11.15
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 10.82
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.72
TOP2B disturbed the quality of human oocytes with advanced maternal age 10.69
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 10.48
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 10.39
FBXW7 modulates stress response by post-translational modification of HSF1 10.39
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 10.22
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 10.04
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 9.97
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 9.54
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.3
Knockdown of ADNP in HCT116 colon cancer cells 9.09
DART-seq: an antibody-free method for global m6A detection 9.07
Global Mapping of Human RNA-RNA Interactions 9.06
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 8.93
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 8.87
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 8.81
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 8.69
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 8.66
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 8.49
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 8.41
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 8.39
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.74
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 7.73
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 7.61
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.61
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 7.58
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 7.48
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 7.43
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 7.41
Genome-wide discovery of human splicing branchpoints 7.41
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 7.35
HNRNPL and its RNA Targets in Prostate Cancer 7.35
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 7.33
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 7.32
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 7.08
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 7.08
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.04
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 6.92
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 6.83
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 6.83
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 6.82
TCF7L1 knockdown in pancreatic cancer 6.78
The evolution of N6-methyladenosine in primates 6.61
LncRNA expression profiling of ischemic stroke patients 6.58
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 6.48
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 6.46
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.39
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 6.39
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.36
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 6.25
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 6.18
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.17
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.15
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.15
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 6.06
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 5.94
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 5.88
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.86
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 5.8
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 5.68
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 5.68
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.66
Tracking of dCas9-methyltransferase footprints 5.66
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.58
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 5.49
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 5.48
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 5.4
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 5.38
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.34
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.24
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 5.21
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 5.21
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 5.2
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 5.16
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.13
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 5.12
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.1
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 5.1
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 5.08
Effect of drugs on transcriptomic profiles 5.06
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 5.05
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 5.05
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 5.01
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.99
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 4.97
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.95
Expression by CD133+ cells isolated from the adult human exocrine pancreas 4.94
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.92
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 4.91
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.9
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.89
Capturing the Interactome of Newly Transcribed RNA 4.86
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.86
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 4.86
The regulartory role of ZCCHC24 in splicing machinery 4.84
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 4.82
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 4.78
MAIT cell RNA sequencing 4.76
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 4.7
ETV7 and interferon response 4.7
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 4.68
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 4.66
Transcriptional landscape changes during human embryonic stem cell derivation 4.63
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 4.59
Developmental stage specific chromosome architecture in human erythroid cells 4.59
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 4.56
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 4.54
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 4.47
Seletive inhibition of CDK9 in DLBCL cell lines 4.43
LncRNA-GAS5 negative regulation of YAP-target genes expression 4.42
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.4
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.39
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 4.37
Gene expression in PANC1 cells treated with Rakicidin 4.36
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.36
RNAseq Study in CC-671 Treated Cal-51 Cells 4.36
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 4.34
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 4.33
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 4.32
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 4.3
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 4.3
RNA-seq of tumor cells following angiopellosis extravasation 4.29
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.29
mRNA expression profile of Lymphocytes 4.29
Human Treg NaCl stimulation 4.28
hTERT promotes cell adhesion and migration independent of telomerase activity 4.27
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 4.26
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 4.25
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 4.25
Hepatitis C virus functionally sequesters miR-122 4.24
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.24
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 4.2
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 4.2
Crizotinib v. DMSO in SW480 cells 4.19
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 4.19
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 4.18
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 4.15
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.15
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 4.15
In vitro modeling of human germ cell development using pluripotent stem cells 4.13
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 4.12
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 4.11
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 4.1
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 4.09
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 4.09
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 4.09
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.04
Differentially expressed vascular development genes for iPSC-ECs from CDI 3.99
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 3.99
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 3.98
The interplay between SOX4 and SMAD3 in the context of breast cancer 3.98
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 3.98
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 3.98
The contribution of Alu exons to the human proteome 3.98
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 3.97
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.97
Effect of Hotair overexpression in human breast cancer cell lines 3.97
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 3.97
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.95
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 3.91
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 3.91
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 3.91
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.9
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.9
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.89
Regulation of protein translation during mitosis 3.88
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 3.87
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.86
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 3.84
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 3.84
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 3.84
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 3.83
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 3.83
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.83
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.8
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.79
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 3.79
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 3.77
Transcriptome of diurnal human blood neutrophils 3.77
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.74
U2AF1 mutations alter splice site recognition in hematological malignancies 3.72
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 3.71
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 3.69
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 3.69
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.68
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.63
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.61
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 3.58
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 3.57
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 3.55
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 3.53
Examining serotonergic neuron differentiation from human iPSCs 3.53
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.48
RNA-seq analysis of control and Myc-induced U2OS cells 3.47
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.44
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.44
Transcriptome of human ILC2s; primary vs IL-1b-primed 3.4
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 3.4
Genome-wide discovery of human splicing branchpoints [RNAse] 3.4
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 3.38
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 3.38
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.37
Role of COP1 on MAP kinase transcriptional output in melanoma 3.35
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.34
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.33
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 3.32
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 3.26
Identification of renal resident macrophages across species [C1] 3.23
RNA-seq of Single-Cell Genotyping of Transcriptomes 3.22
Single-Cell Genotyping of Transcriptomes 3.22
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.19
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 3.14
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.14
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 3.14
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 3.14
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 3.13
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 3.13
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.13
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.13
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 3.1
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 3.1
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.08
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 3.07
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.06
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 3.03
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 3.03
Identification of renal resident macrophages across species 3.03
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 3.02
Silencing p300 in MCF7 cells to study expression and alternative splicing 3.02
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.02
AMPK signaling for naïve pluripotency [Hs] 3.01
AMPK signaling for naïve pluripotency 3.01
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.0
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.0
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 2.99
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 2.93
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 2.9
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 2.89
Fibroblasts in cholesteatoma activate osteoclasts. 2.89
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 2.89
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 2.89
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.88
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 2.88
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 2.88
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 2.87
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.86
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 2.85
O-glcnAc reprograms cellular energetics 2.83
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.79
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.79
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.79
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 2.79
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.77
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.77
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 2.74
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.71
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.71
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.7
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.67
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.66
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.65
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.65
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.64
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.64
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 2.64
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.63
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 2.61
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.58
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.58
Mapping interactions for the TNIP2 hub protein 2.56
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.55
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.54
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.54
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.54
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 2.53
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 2.53
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 2.53
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.52
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.48
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.48
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.48
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 2.41
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.39
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 2.38
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 2.36
RNA sequencing of human mammary epithelial cells 2.34
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.34
Regulation of poly(A) tail and translation during the somatic cell cycle 2.32
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.3
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.3
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.3
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 2.29
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 2.29
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 2.27
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.19
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.15
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.12
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.09
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.08
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.08
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.07
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.07
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.07
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.06
Gene expression signatures of innate lymphoid cells from human blood 2.05
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.04
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.03
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 2.01
PRDM1 inhibits proliferation of human colon cancer organoids 1.99
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.98
Transcriptional profile in human S. haematobium infection 1.97
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 1.96
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 1.95
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 1.94
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 1.9
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.89
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 1.87
An optimization system for isolating and sequencing of single human colon cancer cells 1.87
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.87
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.86
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.8
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.78
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.76
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.75
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 1.73
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.73
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 1.71
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 1.7
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 1.7
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.67
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.65
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.65
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.65
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.62
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.61
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.6
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 1.6
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.6
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.6
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.59
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.58
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.58
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.57
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.57
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.55
Functional significance of the HIV-1 Tat signature amino acid residues 1.52
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.52
Lysine benzoylation is a novel histone mark 1.51
Lysine benzoylation is a novel histone mark [RNA-seq] 1.51
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.51
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 1.51
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 1.51
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 1.5
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.5
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.47
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 1.46
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 1.46
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.43
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.41
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.4
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.38
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.37
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.37
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.37
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.34
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 1.34
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.33
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.31
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.31
Transcription elongation regulates genome 3D structure 1.29
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.25
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.25
scRNASeq analysis of cycling cardiomyocytes 1.22
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.2
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.19
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.17
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 1.14
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.13
CD73 knockdown effect in pancreatic cancer cell lines 1.13
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.11
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.1
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.1
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.08
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.08
Direct Isolation and Characterization of Human Nephron Progenitors. 1.04
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.03
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.01
K562 polyA RNA-Seq 0.99
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.99
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.98
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.98
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.97
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.96
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.96
Transcriptional profiling of LS1034 cells treated with tepoxalin 0.96
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.96
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.95
Transcriptome sequencing of K-562 cells 0.91
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.88
Role of FGFR1 in neuronal devlopment 0.84
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 0.82
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 0.82
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.79
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 0.79
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 0.78
The MEF2B Regulatory Network - RNA-seq data 0.78
The MEF2B Regulatory Network 0.78
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.77
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.77
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.76
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.75
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.75
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.75
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 0.72
Differentiation enhances Zika virus infection in neuronal brain cells 0.68
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.64
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.64
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.63
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.61
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.58
RNA-seq data 0.57
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.54
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.54
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 0.52
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.52
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 0.51
Peptidomimetic blockade of MYB in acute myeloid leukemia 0.51
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 0.51
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.49
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.48
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.47
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.47
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.45
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.45
Modulation of nonsense-mediated decay by rapamycin 0.42
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.41
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.41
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.39
Metastasis in triple-negative breast cancer 0.39
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.38
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.38
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.37
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.37
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.35
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.34
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 0.33
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.32
Total RNA-Seq data from leukemic patients with complex structural variants 0.31
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.29
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.26
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.26
Transcriptome-wide modulation of splicing by the exon junction complex 0.26
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.26
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.23
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.22
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.22
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.21
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.21
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.19
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.19
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.17
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.16
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.15
Aging-associated patterns in the expression of human endogenous retroviruses 0.14
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.13
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.12
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.12
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.1
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.1
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.1
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.09
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.08
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.08
HBEC-shp53-PCHD7 0.06
Human Treg IL-12 stimulation 0.06
Identification of a LIF-responsive replication-competent human β cell 0.06
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.03
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.02
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.01
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation